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Adaptive stress responses activated uponmitochon-
drial dysfunction are assumed to arise in order to
counteract respiratory chain deficiency. Here, we
demonstrate that loss of DARS2 (mitochondrial
aspartyl-tRNA synthetase) leads to the activation of
various stress responses in a tissue-specific manner
independently of respiratory chain deficiency.
DARS2 depletion in heart and skeletal muscle leads
to the severe deregulation of mitochondrial protein
synthesis followed by a strong respiratory chain
deficit in both tissues, yet the activation of adaptive
responses is observed predominantly in cardiomyo-
cytes. We show that the impairment of mitochondrial
proteostasis in the heart activates the expression of
mitokine FGF21, which acts as a signal for cell-
autonomous and systemic metabolic changes.
Conversely, skeletal muscle has an intrinsic mecha-
nism relying on the slow turnover of mitochondrial
transcripts and higher proteostatic buffering capac-
ity. Our results show that mitochondrial dysfunction
is sensed independently of respiratory chain defi-
ciency, questioning the current view on the role of
stress responses in mitochondrial diseases.
INTRODUCTION
Mitochondria are organelles found in almost every eukaryotic
cell. They produce a bulk of cellular energy in the form of ATP,
which is required for numerous processes in the cell. Therefore,
it is not surprising that mitochondrial defects lead to the develop-
ment of different pathologies and can contribute to aging (Ze-
viani and Di Donato, 2004). Although mitochondria are ubiqui-
tous, each mitochondrial disease has a distinctly different
pattern of tissue and organ involvement. The tissue specificity
of mitochondrial diseases is poorly understood. Different organ458 Cell Metabolism 19, 458–469, March 4, 2014 ª2014 Elsevier Inc.presentations in diseases caused by mitochondrial DNA
(mtDNA) mutations are often assigned to a skewed hetero-
plasmy (disproportionately high levels of the mutation in a given
tissue) and different thresholds for disease presentation in
various tissues (Zeviani and Di Donato, 2004). However, even
mutations in nuclear encoded proteins that obey laws of Mende-
lian genetics and have the same defect in all cell types show
tissue-specific presentation (Ro¨tig, 2011). This led to the impres-
sion that tissue-specific parameters, including stress responses
activated by mitochondrial dysfunction in different cell types,
have to be considered. Many different stress responses have
been described in mitochondria, including retrograde signaling
leading to the upregulation of mitochondrial biogenesis, antiox-
idative response, and, more recently, mitochondria-specific
unfolded protein response (UPRmt). Respiratory deficiency,
causing a decreased production of ATP, is considered to be
the primary activator of most of these adaptive responses in
the course of mitochondrial diseases. However, we have a
very limited knowledge about signaling cascade involved in
these responses, whereas the mechanisms that regulate tissue
specificity are essentially unknown.
Eased by advantages in whole-genome sequencing, a large
number of mutations in nuclear genes encoding mitochondrial
aminoacyl-tRNA synthetases (mtARSs) that give rise to surpris-
ingly different diseases were recently discovered (Cassandrini
et al., 2013; Go¨tz et al., 2011; Sasarman et al., 2012; Scheper
et al., 2007). These essential enzymes are responsible for the first
step in protein synthesis that involves covalently attaching an
amino acid to its cognate tRNA. This process, referred to as
tRNA charging or loading, is performed by mtARSs that differ
from their cytoplasmic counterparts.
In the present study, we developed a mouse model lacking a
protein directly involved in mitochondrial translation and
analyzed the tissue-specific adaptations to this deficiency. We
generated Dars2 knockout mice and showed that the loss of
this protein is indispensable for early mammalian development.
Tissue-specific DARS2 depletion leads to comparable mito-
chondrial respiratory deficiency in heart and skeletal muscle,
yet both tissues rely on different strategies in order to cope
with severe mitochondrial dysfunction caused by uncoordinated
Figure 1. Development and Analysis of Dars2 Knockout Mice
(A) Targeting strategy for the conditional disruption of Dars2 gene.
(B) Genotyping analysis of wild-type (+/+), heterozygous (+/), or homozygous knockout (/) Dars2 animals. DNA fragments corresponding to the wild-type
(475 bp) and knockout (1,100 bp) Dars2 loci are indicated.
(C) Morphology of a wild-type and two homozygous knockout embryos at E8.5. The scale bar represents 100 mm.
See also Figure S1.
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specific adaptive stress responses in DARS2-deficient mice
arise independently of respiratory chain deficiency.
RESULTS
DARS2 Is Essential for Embryonic Development in Mice
To determine the in vivo function of DARS2 in mammals, we
ubiquitously disrupted the murine gene by the ACTB-cre-medi-
ated recombination (Figures 1A and 1B). Intercrossing of
Dars2+/ mice produced no viable homozygous knockouts
(Dars2/), whereas the other two genotypes were recovered
at expected Mendelian proportions. Genotyping confirmed that
a quarter of embryos with a clear mutant appearance, derived
from Dars2+/ intercrossing at E8.5 (embryonic day 8.5 [E8.5]),
were Dars2/ mice (Figures 1B and 1C). Therefore, loss of
DARS2 causes embryonic lethality at around the time of organ-
ogenesis, and the observed phenotypes highly resemble other
models deficient for proteins involved in mtDNA maintenance
and/or expression (Hance et al., 2005; Larsson et al., 1998;
Park et al., 2007).
Heterozygous Dars2+/ mice developed normally and dis-
played no obvious phenotype at 2 years of age. Blue native
PAGE (BN-PAGE) analysis of mitochondrial proteins isolated
from liver, heart, and skeletal muscle showed no reduction in
steady-state levels of different OXPHOS complexes nor
decrease in in-gel activities of complex I (NADH:ubiquinone
oxidoreductase, EC 1.6.5.3) and complex IV (cytochrome c oxi-
dase [COX], EC 1.9.3.1) (Figures S1A–S1D available online), sug-Cegesting that one copy of the gene is sufficient to sustain profi-
cient mitochondrial protein synthesis. This is in agreement with
data obtained from human heterozygous mutation carriers in
Dars2 gene (Scheper et al., 2007).
DARS2 Deficiency Leads to Early Pathological Changes
in Heart and Skeletal Muscle
Next, we disrupted the gene in a tissue-specific manner by
breeding Dars2loxP/loxP animals with mice expressing cre recom-
binase under the muscle creatine kinase promoter (Ckmm-cre).
This promoter is fully active in heart and skeletal muscle after
E15.5 (Lyons et al., 1991), and we confirmed a complete loss
of DARS2 in both tissues at 6 weeks of age (Figure 2A). Liver ex-
tracts were used as a negative control throughout the experi-
ments. The resulting Dars2loxP/loxP,+/Ckmm-cre mice (hereafter,
DARS2-deficient mice) developed cardiomyopathy character-
ized by a strong increase in heart size with increasing age (Fig-
ures 2B and 2C), whereas the maximal lifespan was severely
shortened to only 6–7 weeks. We detected clear signs of degen-
eration in both tissues at 6 weeks of age, as measured by the
increased expression of hypertrophy markers Nppa and Nppb
in heart and atrophy markers MuRF1 and Atrogin1 in skeletal
muscle (Figure 2D). Although we found no change in the expres-
sion of myogenic markers Myod1 and Myf5 (Figure 2D),
increased numbers of cells with centrally positioned nuclei sug-
gest a possible upregulation of skeletal muscle regeneration in
DARS2-deficient mice (Figure 2E).
Ultrastructural analysis showed the disruption of myocardial
organization with the accumulation of mitochondrial mass inll Metabolism 19, 458–469, March 4, 2014 ª2014 Elsevier Inc. 459
Figure 2. Phenotypic Characterization of Tissue-Specific DARS2 Deficiency in Heart and Skeletal Muscle
(A) Western blot analysis of DARS2 protein levels in the heart, skeletal muscle (SkM), and liver of control (L/L) and Dars2 tissue-specific knockout mice (L/L, cre)
mice. Asterisks indicate unspecific proteins.
(B) Heart weight to body weight ratio in mice at 3, 4, and 6 (n = 5–9) weeks of age.
(C) Heart and SkM morphology of 6-week-old mice.
(D) Relative expression levels of cardiac hypertrophy markers (Nppa and Nppb), muscle atrophy markers (MuRF1 and Atrogin-1), and myogenic factors (Myod1
and Myf5) in 3- and 6-week-old mice (n = 6).
(E) Hematoxylin and eosin staining of muscle sections from 6-week-old mice. Arrowheads indicate fibers with centrally located nuclei. The scale bar represents
100 mm.
(F) Transmission electron micrographs (the scale bar represents 1 mm). Enzyme histochemical double staining for COX and SDH activities (COX-SDH) and
Masson’s trichrome staining (scale bars represent 100 mm; n = 4). Arrowheads indicate SDH-positive cells.
Error bars represent mean ± SEM. Asterisks indicate the level of statistical significance (Student’s t test; *p < 0.05, **p < 0.01, ***p < 0.001).
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decrease in muscle size, we only sporadically observed long,
fused mitochondria with no increase in mitochondrial mass460 Cell Metabolism 19, 458–469, March 4, 2014 ª2014 Elsevier Inc.and no major changes in fiber organization (Figures 2C and
2F). Strong respiratory chain deficiency (COX deficiency)
accompanied by increased fibrosis (Masson’s trichrome
Figure 3. Characterization of Mitochondrial
Dysfunction in 6-Week-Old DARS2-Deficient
Heart and Skeletal Muscle
(A) Relative MRC complex activities in isolated heart
and SkM mitochondria of DARS2-deficient mice
(L/L, cre) presented as a percentage of control (L/L;
n = 5).
(B) Coomassie Brilliant Blue staining of BN-PAGE
with indicated position of specific complexes I–V.
(C) Western blots for MRC complexes. Antibodies
against individual MRC subunits (indicated on the
left) were used to detect MRC complexes (com-
plexes I–V, indicated on the right).
(D and E) In-gel activity of complexes I (D) and IV (E)
performed after BN-PAGE (n = 4).
(F) Representative gel of in organello translation in
heart, SkM, and liver mitochondria (n = 4). Positions
of individual mitochondria encoded proteins are
indicated.
(G) Quantification of mitochondrial mRNA and tRNA
levels in heart and SkM presented as a percentage
of control (n = 5).
(H) Aminoacylation assay for mitochondrial mt-Td
and mt-Tk in heart and SkM. Positions of charged
(AA-mt-Taa) and uncharged tRNAs (mt-Taa) are
indicated.
(I) In organello transcription assay in heart and SkM
mitochondria (n = 5). Mitochondrial transcripts are
isolated immediately after labeling with a-32P-UTP
(0) or after 3 (3) and 6 hr (6) of cold chase. Steady-
state Cox2 transcript levels are used as a loading
control (Ctr). Error bars represent mean ± SEM.
Asterisks indicate the level of statistical significance
(Student’s t test; *p < 0.05, **p < 0.01, ***p < 0.001,
****p < 0.0001).
See also Figure S2.
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deficient cardiomyocytes also showed high succinate dehydro-
genase (SDH) activity (blue staining), consistent with the
observed increase inmitochondrial mass (Figure 2F). In contrast,
very few skeletal muscle fibers showed elevated SDH activity
(Figure 2F), and we did not observe ragged red fibers (data not
shown), which are often detected in patients with mitochondrial
myopathies (Zeviani and Di Donato, 2004).
Deregulation ofMitochondrial Protein Synthesis Results
in Strong Mitochondrial Respiratory Chain Deficiency
Next, we analyzed the level of mitochondrial respiratory chain
deficiency in the two tissues. We observed a comparable
decrease inmitochondrial respiratory chain (MRC) enzyme activ-
ities and a general reduction in all inducible respiratory states inCell Metabolism 19, 458–6-week-old heart and skeletal muscle
mitochondria from DARS2-deficient mice
(Figures 3A, S2A, and S2B). We detected
a strong decrease in the steady-state
levels of complex IV subunits and amoder-
ate reduction in the levels of complexes I
and III (ubiquinol cytochrome-c reductase,
EC 1.10.2.2) subunits in both tissues (Fig-
ure S2C). The observed decrease in the
level of individual MRC subunits resultedin a corresponding reduction in the amount of fully assembled
complexes I, III, and IV in both heart and skeletal muscle (Figures
3B and 3C). The reduction of complex I and IV levels was
mirrored by the decrease in in-gel activity in both tissues (Figures
3D and 3E, respectively).
We detected a strong deregulation of de novo protein synthe-
sis in DARS2-deficient mitochondria from heart and skeletal
muscle (Figures 3F and S2D), whereas the turnover rates seem
to be rather slow in comparison to liver mitochondria and un-
changed between the two tissues after 3 hr of cold chase (Fig-
ure S2E). This analysis also revealed an additional polypeptide
with a slightly lower molecular mass than ATP synthase F0 sub-
unit 6 (ATP6), which is most likely a truncated form of this protein
lacking the last two residues, including the only aspartate in the
ATP6 polypeptide (Figure 3F, highlighted box). The observed469, March 4, 2014 ª2014 Elsevier Inc. 461
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completely lacks aspartate residues is most likely a conse-
quence of increased number of ribosomes inside DARS2-defi-
cient mitochondria (Figure S2F). Remarkably, the upregulation
of mitochondrial ribosomal subunits is observed in isolatedmito-
chondria from both tissues, although the upregulation was less
severe in skeletal muscle (Figure S2F).
We detected a general upregulation of mitochondrial tran-
script levels (mt-mRNAs) primarily in DARS2-deficient hearts,
whereas mt-Cytb levels were also increased in skeletal muscle
mitochondria (Figures 3G and S2G). Increased mitochondrial
mass could in part account for at least the observed increase
in mt-mRNAs in cardiomyocytes.
Although pathogenic mutations in some aminoacyl-tRNA syn-
thetases lead to a decrease in the level of cognate tRNAs (Belos-
totsky et al., 2011; Edvardson et al., 2007), we found no changes
in the steady-state levels of mitochondrial tRNAs, includingmito-
chondrial aspartic acid (mt-Td) (Figures 3G and S2G). We also
analyzed the level of tRNA aminoacylation by the separation of
charged and uncharged forms of mt-Td under acidic conditions.
Although a full separation of the two forms, as shown for mito-
chondrial tRNA lysine (mt-Tk), cannot be achieved for mt-Td
(Enrı´quez and Attardi, 1996), we could observe minute, yet
detectable, shift in control in comparison to DARS2-deficient
mitochondria, especially in skeletal muscle samples, suggesting
that the majority of mt-Td in this tissue is present in uncharged
form (Figure 3H). The separation of two forms was less clear in
heart samples, leaving open the possibility that some other
aminoacyl-tRNA synthetases partially charges mt-Td in
DARS2-deficient hearts. However, our other results, in particular
the de novo protein synthesis, argue against this possibility.
Next, we tested whether Dars2 deletion affects the rate of de
novo mitochondrial transcription and turnover of mtRNAs.
Though both tissues have similar de novo transcription rates,
we observed slower turnover rate of skeletal muscle mitochon-
drial transcripts in both control and DARS2-deficient skeletal
muscle fibers (Figure 3I). This is in agreement with previous re-
ports showing up to 10-fold higher stability of transcripts encod-
ing MRC subunits or proteins that regulate their expression
(TFAM, PGC-1a, and nuclear respiratory factor 1) in skeletal
muscle than in the heart, whereas the rates of mRNA decline
for other mitochondrial proteins were unchanged (Connor
et al., 1996; D’souza et al., 2012).
Mitochondrial Stress Responses Are Activated
Exclusively in DARS2-Deficient Heart
Intrigued by our initial observation of increased mitochondrial
mass in heart, but not in skeletal muscle of DARS2-deficient
mice, we carried additional experiments in order to analyze
different stress responses originating from respiratory-deficient
mitochondria into tissues. First, we further analyzed mitochon-
drial retrograde signaling in DARS2-deficient animals by
measuring parameters commonly used to estimate mitochon-
drial mass within a cell. We detected increase in mitochondrial
biogenesis markers, such as citrate synthase activity, PGC-1a
(a master regulator of mitochondrial biogenesis), TFAM (pack-
ages mtDNA in a histone-like manner), and mitochondrial DNA
levels in only DARS2-deficient hearts (Figures S3A–S3D). These
data suggest that a strong defect in MRC function caused by462 Cell Metabolism 19, 458–469, March 4, 2014 ª2014 Elsevier Inc.DARS2 depletion leads to an upregulation of mitochondrial
biogenesis only in cardiomyocytes, and other pathways could
be involved in adaptive responses in DARS2-deficient skeletal
muscle.
Mitochondrial dysfunction is often accompanied by increased
reactive oxygen species (ROS) production that leads to accumu-
lation of oxidized proteins and upregulation of antioxidant
responses in the cell. However, we found no difference for
increased protein carbonylation, nor did we find evidence for
the activation of oxidative stress responses measured by the
levels of SOD2, a major mitochondrial ROS scavenging enzyme,
in DARS2-deficient heart or skeletal muscle (Figures S3E and
S3F), consistent with our previous finding that general MRC defi-
ciency does not affect ROS production (Trifunovic et al., 2005).
DARS2 deficiency directly interferes with the mitochondrial
protein synthesis and therefore could affect mitochondrial pro-
teostasis, leading to the activation of recently described UPRmt
(Haynes and Ron, 2010). Indeed, in heart mitochondria, we
detected increased levels of LONP1 and ATPase family gene
3-like 2 (AFG3L2) proteases involved in the turnover of misfolded
proteins (Figures 4A and S3G). Furthermore, a level of the two
main mitochondrial chaperones (mtHSP70/HSPA9 and HSP60/
HSPD1) were upregulated, confirming UPRmt activation in 6-
week-old hearts (Figures 4A and S3G). We also observed the
suppression of LC3B-I to LC3B-II conversion (Figure 4B) and
the accumulation of SQSTM1/P62 (Figures 4B and 4C), suggest-
ing a reduction in autophagy in DARS2-deficient hearts. This was
further supported by the lack of autophagosomes on multiple
heart sections analyzed by transmission electron microscopy.
Levels of ATG7, ATG12, and BECLIN-1 were not affected (Fig-
ure S3H). We observed no changes in LC3B-I:LC3B-II ratio or
the accumulation of P62 in DARS2-deficient skeletal muscle
(Figure 4B), even in rare SDH-positive fibers (Figure S3I). In
agreement with a reduction in autophagy and perturbations in
protein folding environment, we detected somewhat higher
levels of polyubiquitinated (poly-UQ) proteins exclusively in
DARS2-deficient hearts (Figures 4D and 4E). Identical changes
were observed in hearts where autophagy was directly sup-
pressed by knockdown of autophagy-related protein 5 (Atg5)
or Atg7 (Nakai et al., 2007).
We speculate that MRC deficiency in DARS2-deficient skel-
etal muscle might not have reached a threshold for the activation
of stress responses observed in heart mitochondria. To test this,
we analyzed DARS2-deficient heart mitochondria at 3 weeks of
age, which showed no obvious signs of mitochondrial cardiomy-
opathy (Figure 2).
Early Disturbance in Mitochondrial Proteostasis
Triggers Stress Responses in Heart Independent
of MRC Deficiency
The MRC enzyme activities in 3-week-old DARS2-deficient
hearts were only marginally downregulated, consistent with a
mild-to-moderate changes in the level of assembled MRC com-
plexes (complexes IV and V and ATP synthase, EC 3.6.3.14) and
no obvious change in the in-gel activities of complexes I and IV
(Figures 5A–5E) or COX activity on tissue sections (Figure S4A).
Although only minimal changes in MRC complex levels or activ-
ities were observed in 3-week-old mice, we found evidence for
the activation of stress signals, namely mitochondrial retrograde
Figure 4. Mitochondrial Stress Responses in 6-Week-Old DARS2-Deficient Heart and Skeletal Muscle
(A) Western blot analysis of CLPP, mtHSP70, LONP1, HSP60, and AFG3L2 levels in heart and SkM of control (L/L) and DARS2-deficient mice (L/L, cre).
(B) Western blot analysis of LC3B and P62 levels in heart and SkM.
(C) P62 (green) immunostaining of heart sections. DAPI staining (blue). The scale bar represents 100 mm.
(D and E) Western blot analysis (D) and quantification (E) of poly-UQ proteins in total protein extracts of heart and SkM. Error bars represent mean ± SEM
(Student’s t test; p value is indicated over the error bar; n = 4–6).
See also Figure S3.
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regulation of autophagy, illustrated by changed LC3B-I:LC3B-II
ratio and increased P62 levels (Figures 5F and S4A). This sug-
gests that mechanisms other than respiratory chain deficiency
are the primary activators of adaptive changes in DARS2-defi-
cient hearts.
Recently, it was shown that mitochondrial dysfunction acti-
vates fibroblast growth factor 21 (Fgf21) transcription in aCedose-dependent manner (Tyynismaa et al., 2010). We found a
vast increase (250-fold) in the Fgf21 expression already at
3 weeks of age that persisted at 6 weeks of age (Figure 5G), re-
sulting in higher circulating levels of FGF21 (Figure S4B). Inter-
estingly, in control mice, heart contributes very little to FGF21
production that stems primarily from liver (Table S1) and can
also be produced by adipocytes and skeletal muscle (Potthoff
et al., 2012). However, we clearly show that DARS2 deficiencyll Metabolism 19, 458–469, March 4, 2014 ª2014 Elsevier Inc. 463
Figure 5. Characterization of Mitochondrial Dysfunction and Stress Responses in 3-Week-Old DARS2-Deficient Heart and Skeletal Muscle
(A) Relative MRC complex activities in heart and SkM mitochondria of DARS2-deficient mice (L/L, cre) presented as a percentage of control (L/L; n = 5).
(B–E) BN-PAGE analysis of respiratory chain complexes.
(B) Coomassie Brilliant Blue staining of BN-PAGE with the indicated position of specific complexes.
(C) Western blots for MRC complexes. Antibodies against individual MRC subunits (indicated on the left) were used to detect MRC complexes (complexes I–V,
indicated on the right).
(D and E) In-gel activity of complexes I (D) and IV (E) performed after BN-PAGE (n = 4).
(F) Western blot analysis with corresponding quantification of PGC-1a, P62, and LC3B levels. HSC70 is used as loading control (Ctr; n = 5).
(G) Fgf21 expression levels in heart, SkM, white adipose tissue (WAT), brown adipose tissue (BAT), and liver of 3- and 6-week-old mice (n = 6).
(legend continued on next page)
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Figure 6. Characterization of Mitochondrial
Proteostasis in 3-Week-Old DARS2-Deficient
Hearts
(A) Relative quantification of proteins involved in
UPRmt (CLPP, HSP60, LONP1, mtHSP70, and
AFG3L2) in 3-week-old of DARS2-deficient hearts
(L/L, cre) normalized to control (L/L; n = 5).
(B) Relative expression levels of MRC subunits
(n = 5).
(C) Representative gel of in organello translation and
corresponding Coomassie Brilliant Blue-stained gel
used as loading control.
(D) Relative quantification of steady-state levels of
MRC subunits (n = 4).
(E) Proposed model for the heart-mediated stress
responses to perturbed protein homeostasis
caused by DARS2 deficiency. Error bars represent
mean ± SEM. Asterisks indicate the level of statis-
tical significance (Student’s t test; *p < 0.05, **p <
0.01; n = 5–6).
See also Figure S5.
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influences the circulating levels, given that we detected no
changes in Fgf21 expression in liver, skeletal muscle, and white
or brown adipocyte tissue (Figure 5G and Table S1). In agree-(H) Relative expression levelsAtf4, Atf5 andChop in heart and SkM of 1-, 3- and 6-week-old mice, including F
G and H represent fold increase in comparison to respective control that was normalized to 1. Error bars re
statistical significance (Student’s t test, *p < 0.05, **p < 0.01, ***p < 0.001).
See also Figure S4 and Table S1.
Cell Metabolism 19, 458–ment with increased FGF21 levels, we
detected higher circulating free fatty
acid levels, lower blood glucose, and
decreased fat mass in 6-week-old
DARS2-deficient animals (Figures S4C–
S4G). Therefore, mitochondrial dysfunc-
tion in the heart, through increased cardiac
Fgf21 expression, seems to be responsible
for adaptive systemic changes in themeta-
bolism of the whole animal.
High amounts of FGF21 are most likely
responsible for the upregulation of
steady-state PGC-1a levels, given that
we detected no changes in Pgc-1a tran-
scripts (Figure S4F), in agreement with
the previous reports showing that FGF21
mediates PGC-1a stabilization without
affecting the expression of this protein
(Fisher et al., 2012). The expression of
Fgf21 is regulated by PPARa and ATF4,
two transcription factors involved in
different types of adaptive stress re-
sponses (Potthoff et al., 2012). We de-
tected the downregulation of Ppara that
normally induces Fgf21 expression in liver
upon fasting (Figure S4F) (Potthoff et al.,
2012). In contrast, we found high upregula-
tion of Atf4 and also Chop and Atf5 (Fig-
ure 5H), transcription factors directlyinvolved in the regulation of protein homeostasis in the cell
(Wek and Cavener, 2007). ATF5 (mammalian homolog of
C. elegans ATFS-1) and CHOP are transcription factors that
mediate the activation of UPRmt (Horibe and Hoogenraad,gf21 levels in 1-week-oldmice (n = 5). Results under
present mean ± SEM. Asterisks indicate the level of
469, March 4, 2014 ª2014 Elsevier Inc. 465
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tion factors in 3-week-old DARS2-deficient hearts was accom-
panied by increased levels of all major mitochondrial proteases
(Figures 6A and S5A), including CLPP, shown to be central for
the initial UPRmt signaling, which was not changed in 6-week-
old hearts (Figure 4A). We also detected increase in the amount
of poly-UQ proteins in the cardiomyocytes from 3-week-old
animals (Figures S5B and S5C), adding evidence for the distur-
bance in proteostasis. None of these changes were observed
in 3-week-old skeletal muscle from the same animals (data not
shown).
We believe that impaired mitochondrial proteostasis acts as
an initial signal that activates different stress response observed
in DARS2-deficient heart mitochondria. The very first changes
observed in 1-week-old DARS2-deficient hearts are mild upre-
gulation of UPRmt transcription activators Atf5 and Chop, and
a 6-fold increase in Fgf21 levels (Figures 5H and S5D). These re-
sults indicate that the activation of UPRmt occurs very early and
precedes any other changes (Figure S5D), including decrease in
the steady-state levels of MRC subunits or activation of other
stress responses detected at 3 and 6 weeks of age in DARS2-
deficient hearts. The upregulation of Fgf21 expression coincides
with the increase in the UPRmt transcription activators, indicating
that this cytokine is, indeed, a very early marker of mitochondrial
dysfunction independent of respiratory deficiency and suggest-
ing that Fgf21 could be a direct target of UPRmt.
Impaired protein homeostasis is most likely a consequence of
the increased amount of unfolded and/or unassembled proteins
accumulating in DARS2-deficient heart mitochondria. We de-
tected an increase in different mitochondrial transcripts that
was reflected in a higher de novo protein synthesis in 3-week-
old DARS2-deficient hearts (Figures 6B and 6C). Remarkably,
analysis of steady-state levels of different MRC subunits re-
vealed a clear decrease in the level of complex IV subunits,
both nuclear and mtDNA encoded (Figures 6D and S5E), in
agreement with our previous results showing mild-to-moderate
decrease in the level of fully assembled complex IV (Figure 5C).
These findings identify an increased protein turnover of mtDNA-
and nucleus-encoded MRC subunits, adding evidence for
the disrupted protein folding environment in DARS2-deficient
hearts.
Altogether, our data show that increases in the level of
unfolded and unassembled proteins act as an initial signal for
the activation of stress responses that is independent of respira-
tory chain deficiency and results in adaptive, cell-intrinsic
changes accompanied by a systemic alteration of metabolism.
DISCUSSION
Our results clearly demonstrate that direct disruption of mito-
chondrial protein synthesis by deletion of Dars2 gene leads to
the activation of cellular stress responses in a tissue-specific
manner. These specific responses are activated in the heart
before any real damage is done to the tissue, and they precede
respiratory chain deficiency. The initial signal for the activation of
cellular stress responses seems to be a significant buildup of
unfolded and/or unassembled respiratory chain subunits due
to the imbalance between the increased levels of de novo protein
synthesis and decreased folding capacity for the mtDNA- and466 Cell Metabolism 19, 458–469, March 4, 2014 ª2014 Elsevier Inc.nucleus-encoded mitochondrial proteins, resulting from aber-
rant protein synthesis. Impaired proteostasis in mitochondria
directs preferential upregulation of stress-related transcriptional
activators such as Atf4, Atf5, and Chop, which in turn activate
signaling cascade, leading to the upregulation of mitochondrial
biogenesis andUPRmt while downregulating autophagy and pro-
vide a systemic change in metabolism. We propose that FGF21
could have a central role in this by mediating both heart-intrinsic
and general metabolic changes in DARS2-deficient mice
(Figure 6E).
Mitochondrial respiratory deficiency caused by inhibition in
autophagy leads to an increase in Atf4 levels and the activation
of Fgf21 expression (Kim et al., 2013). It is currently unclear
whether ATF4 and FGF21 have a direct effect on autophagy
instead, although previous reports show that PGC-1a overex-
pression decreases autophagy (Wenz et al., 2009). Mitochon-
drial respiratory deficiency is supposed to activate mitophagy,
a special form of autophagy that should work as a quality control
mechanism for selective sequestration and subsequent degra-
dation of dysfunctional mitochondria (Youle and Narendra,
2011). Much of our knowledge about mitophagy comes from
in vitro studies, and there is currently very little support for the
role of mitophagy as a quality control mechanism in vivo. Studies
in yeast showed that mitochondrial respiratory deficiency sup-
presses the autophagic flux and recruitment of the ATG1-
ATG3 kinase complex to the preautophagosomal structures
(Graef andNunnari, 2011), which is in agreement with our results.
We demonstrate that a loss of Dars2 in heart and skeletal
muscle leads to a strong and comparable respiratory chain defi-
ciency, yet these tissues developed different strategies to ac-
count for the MRC defects. There is still a certain possibility
that the upregulation of stress responses in 3-week-old
DARS2-deficient heart could mask the underlying respiratory
deficiency that becomes obvious in 6-week-old animals only
when those compensatory mechanisms are overwhelmed.
Nevertheless, this does not explain the lack of recruitment of
these mechanisms in DARS2-deficient skeletal muscle at
6 weeks of age when they show 60%–80% decrease in the ac-
tivity of complexes I, III, and IV and still do not upregulate mito-
chondrial stress responses. Instead, our results argue that skel-
etal muscle has an intrinsic protective mechanism relying
primarily on the slow turnover of mitochondrial transcripts that
is coupled with the possible upregulation of muscle regenera-
tion. This mechanism is most likely an evolutionary adaptation
developed in order to cope with muscle damage and regenera-
tion after periods of intense activity. Although this is not an adap-
tive change specific to mitochondrial dysfunction, it is a very effi-
cient mechanism that could protect skeletal muscle for
prolonged periods of time, particularly from defects in mtDNA
replication or transcription, as shown for Ckmm-cre-mediated
deletion of Tfam (Wang et al., 1999) or mitochondrial transcrip-
tion termination factor 3 (Park et al., 2007), both of which lead
to the development of fatal mitochondrial cardiomyopathy
without accompanying MRC deficiency in skeletal muscle.
Remarkably, the upregulation of ribosomal subunits is the only
change that was observed in both tissues and is likely the conse-
quence of increased number of stalled ribosomes due to a lack
of chargedmt-Td and therefore the creation of so-called ‘‘hungry
codons’’ (Temperley et al., 2010). The mechanism for this
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and is not likely mediated by PGC-1a.
Increased mitochondrial biogenesis in skeletal muscle is a
well-documented phenomenon highlighted by the occurrence
of ragged red fibers in both human patients (Zeviani and Di Do-
nato, 2004) and mouse models for late-onset mitochondrial
myopathy (Tyynismaa et al., 2005; Wredenberg et al., 2002).
Our results argue that mitochondrial stress responses, including
increasedmitochondrial biogenesis, are activated in the heart by
a burden of increased unfolded and/or unassembled MRC sub-
units before respiratory deficiency develops. It is possible that
the intrinsic capacity of young skeletal muscle for folding and
turnover of mitochondrial proteins is much higher than in the
heart and that, in combination with longer protein stability, it pro-
vides an efficient way of coping with increased levels of unas-
sembled proteins. Once this capacity is exceeded, the stress
responses will also be activated in skeletal muscle. Therefore,
it is possible that the upregulation of mitochondrial biogenesis
would also occur in DARS2-deficient skeletal muscle if they
had longer lifespan. Our results suggest that, in this case, the
increased biogenesis would be accompanied with highly
increased Fgf21 levels, as shown for the deleter mouse, a model
for late-onset mitochondrial myopathy (Tyynismaa et al., 2010).
The heart is the most energy-demanding organ in the human
body; therefore, it is not surprising that adaptive stress re-
sponses fail to provide protection fromMRC deficiency. Howev-
er, we wonder whether these stress responses could add to the
progression of cardiomyopathy instead of ameliorating it. A pre-
vious study suggested that increased mitochondrial biogenesis
coupled with metabolic changes in TFAM-deficient hearts do
not compensate for, but rather directly contributed to, heart-fail-
ure progression (Hansson et al., 2004). Furthermore, increased
Pgc-1a expression is beneficial in the neonatal heart, whereas
the same intervention in adult mice leads to a milder increase
in mitochondrial biogenesis, aberrant mitochondrial structure,
and cardiomyopathy (Russell et al., 2004).
Our results provide clear evidence that question current view
on molecular mechanisms leading to the activation of adaptive
responses during the development of mitochondrial diseases.
There is currently no efficient treatment for respiratory chain dis-
eases, and increased knowledge of the tissue-specific patho-
physiology may reveal possible targets that are more accessible
to therapeutic intervention than the respiratory chain dysfunction
per se.
EXPERIMENTAL PROCEDURES
Generation and Genotyping of Dars2-Deficient Mice
Dars2 gene targeting was carried out as part of the International Knockout
Mouse Consortium (KOMP) in the JM8.N4 embryonic stem cell line on a
C57BL/6N genetic background. The targeted Dars2tm1a(KOMP)WTSI allele
carried a gene trap DNA cassette inserted into the second intron of the gene
consisting of a splice acceptor site, an internal ribosome entry site, and a
b-galactosidase reporter followed by a neomycin resistance marker ex-
pressed from an independent b-actin promoter (additional information is
available at http://www.mousephenotype.org/martsearch_ikmc_project/,
project ID 41773). We generated a full-body knockout mice by mating the
Dars2+/tm1a(KOMP)WTSI animals, and transgenic mice ubiquitously expressed
the Cre recombinase. The genotyping primers for the wild-type band are
forwardwt (50- ATGAATTCTAGGCCAGCCAC-30 ) and reversewt (50-TGGCAATC
TCTTAGGACTAAG-30); the genotyping primers for the knockout band areCeforwardko (50- CGCTACCATTACCAGTTGGT-30) and reverseko (50- TGACTGG
CTATAATGCTGAAG-30).
Heart- and skeletal-muscle-specific knockout mice were generated by mat-
ing Dars2loxP/loxP animals with transgenic mice expressing cre recombinase
under the control of muscle creatine kinase promoter (Ckmm-cre) (Larsson
et al., 1998). Unless otherwise indicated, experiments were performed on 6-
week-old mice. Animal protocols were in accordance with guidelines for hu-
mane treatment of animals and were reviewed and approved by the Animal
Ethics Committee of the Nord-Rheine Westphalia, Germany.
BN-PAGE and In-Gel Activity of MRC Complexes
BN-PAGEwas carried outwith theNativePAGENovexBis-TrisMini Gel system
(Invitrogen) according to the manufacturer’s specifications. Complex I in-gel
activity was measured by incubating BN-PAGE gel in NADH 0.1 mg/ml and
nitrotetrazolium blue 2.5 mg/ml in 5 mM Tris (pH 7.4) for 1 hr. Complex IV in-
gel activity was measured by incubating BN-PAGE gel at 37C in 0.24 U/ml
catalase, 10% cytochrome C, and 0.1% diaminobenzidine tetrahydrochloride
in 50 mM Tris (pH 7.4) for 1 hr. One set of samples was transferred to polyviny-
lidene difluoride membrane with the iBlot system (Invitrogen), and immunode-
tection of mitochondrial protein complexes was performed.
Analyses of De Novo Transcription and Translation in Isolated
Mitochondria
In organello transcription assay was performed as previously described (Park
et al., 2007). In brief, after mitochondria isolation, 1 mg mitochondria was re-
suspended in transcription incubation buffer (25 mM sucrose, 75 mM sorbitol,
100 mM KCl, 10 mM K2HPO4, 50 mM EDTA, 5 mM MgCl2, 1 mM ADP, 10 mM
glutamate, 2.5mMmalate, 10mMTris-HCl (pH 7.4), and 1mg/ml BSA) supple-
mented with 50 mCi of a-32P-UTP (PerkinElmer). The samples were incubated
for 1 hr at 37C with gentle rotation for pulse or without radioactivity for 3 and
6 hr of cold chase. After incubation, mitochondria were washed twice with 1ml
of washing buffer (10%glycerol, 10mMTris-HCl [pH 6.8], and 0.15mMMgCl2)
and resuspended in 1 ml of TRIzol Reagent (Invitrogen) for RNA isolation. Iso-
lated RNA was analyzed by northern blotting, and radiolabeled transcripts
were visualized by autoradiography.
In organello translation was performed as previously described in mito-
chondria from the heart and liver (Edgar et al., 2009). Skeletal muscle mito-
chondria were incubated in translation buffer containing 25 mM sucrose,
75 mM sorbitol, 100 mM KCl, 1 mM MgCl2, 0.05 mM EDTA, 10 mM Tris-
HCl, and 10 mM K2HPO4 (pH 7.4) with the addition of 10 mM glutamate,
2.5 mM malate, 1 mM ADP, and 1 mg/ml fatty-acid-free BSA. In organello
proteins synthesis was performed for 1 hr in presence of 35S-met at 37C.
After this period, one-third of mitochondria was isolated by incubation in
the SDS-PAGE loading buffer, whereas the other two-thirds were washed
and incubated for an additional 3 or 6 hr for the cold chase experiment
in a translation buffer containing all amino acids, including methionine. Trans-
lation products were separated by SDS-PAGE, the gel was stained with
Coomassie Brilliant Blue R-250 incubated in Amplify solution (GE
Healthcare) and dried, and newly synthesized polypeptides were detected
by autoradiography.
Analysis of tRNA Aminoacylation
For analysis of the tRNA aminoacylation, total RNA was isolated with TRIzol
(Invitrogen) according to the manufacturer’s protocol. Total RNA was resus-
pended in 0.3 M NaOAc (pH 5.0) and 1 mM EDTA. Aminoacylation status
was determined by acid-urea PAGE with 6.5% (19:1) polyacrylamide and
8 M urea gels in 0.1 M NaOAc (pH 5.0) buffer. Gels were run for 48 hr at 4C
with regular buffer changes. tRNAs were detected with specific g-32P-dATP-
labeled oligonucleotide probes (Park et al., 2007).
Enzyme Histochemistry and Electron Microscopy
Fresh frozen tissues were sectioned and stained for COX and SDH activity
(Edgar et al., 2009), hematoxylin and eosin (Sigma-Aldrich), or Masson’s
trichrome staining kit (Sigma-Aldrich, HT15-1KT) according to the manufac-
turer’s instructions. Staining of P62 (SQSTM1) aggregates was performed
on paraffin sections (1:200, Abnova). Electron microscopy was performed as
described previously (Almajan et al., 2012).ll Metabolism 19, 458–469, March 4, 2014 ª2014 Elsevier Inc. 467
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Isolation of DNA and Southern blot analysis were performed as described pre-
viously (Hance et al., 2005). RNA was isolated with the ToTALLY RNA Total
RNA Isolation Kit (Ambion). Northern blot analysis was performed with
a-32P -dCTP-labeled DNA probes for mt-mRNAs, whereas different tRNAs
were detected with specific g-32P-dATP-labeled oligonucleotide probes
(Park et al., 2007).
Proteins were extracted from homogenized tissue or isolated mitochondria,
and western blot analysis was performed as described previously (Hance
et al., 2005). Primary antibodies were used in the following concentrations:
AFG3L2 (made by E.I.R.), 1:1,000; MRPL13, MRPS-27, and COX2, 1:200;
and mitochondrial transcription factor A (TFAM, a kind gift from N.-G. Larsson,
MPI for Biology of Aging), 1:1,000. All other antibodies were used in dilutions
recommended by the manufacturers: AFG3L2 1:1,000 (polyclonal antisera
made by E.I.R.); MRPL13, MRPS27, and COX2 1:200; TFAM 1:1,000 (a kind
gift from Prof. N.-G. Larsson, MPI for Biology of Aging). All other antibodies
were used in dilutions recommended by the manufacturers: PORIN (Calbio-
chem); ATP5A1 (MitoSciences); COX4-1, UQCRC2, SDHA, NDUFA9,
COX5B, and COX3 (Invitrogen); HSP60 (StressMarq); MnSOD/SOD2 (Milli-
pore); DARS2 and MRPS35 (Proteintech); HSC70 and PGC-1a (Santa Cruz
Biotechnology); CLPP (Sigma-Aldrich); mtHSP70, ND5, MRPL12,and LONP1
(Abcam); LC3B, Ubiquitin, BECLIN-1, ATG7, and ATG12 (Cell Signaling Tech-
nology); and p62/SQSTM1 (Abnova).
Mitochondrial Isolation, Oxygen Consumption Measurements,
and Respiratory Chain Enzyme Activities
Mitochondria were isolated from the heart and liver (Edgar et al., 2009) or skel-
etal muscle (Ferna´ndez-Silva et al., 2007), and oxygen consumption rates were
measured with Oxygraph-2k (Oroboros Instruments). In short, mitochondrial
complex I activity was measured with the addition of 1 mM ADP, 5 mM pyru-
vate, 2 mM malate, and 10 mM glutamate. Then, mitochondrial coupling was
evaluated by the inhibition of ATP synthase by adding 1.5 mg/ml oligomycin
and uncoupling by amultiple-step carbonylcyanide p-trifluoromethoxyphenyl-
hydrazone titration. After the inhibition of complex I by 0.5 mM rotenone, respi-
ratory capacity with substrates for complex II alone were measured with
10 mM succinate as a substrate. Mitochondrial respiration was also measured
in saponin-permeabilized fibers isolated from skeletal muscle, as described
previously (Kuznetsov et al., 2008). The measurements of respiratory chain
enzyme complex activities and citrate synthase activity were performed as
described previously (Wibom et al., 2002).
Analysis of Body Composition
Nuclear magnetic resonance (NMR) was employed in order to determine the
body-fat content of live animals with the NMR Analyzer Minispec mq7.5
(Bruker Optik).
Real-Time Quantitative PCR
Isolated heart RNA was treated with DNase (DNA-free Kit, Ambion) and subse-
quently reverse transcribedwith the High-Capacity cDNAReverse Transcription
Kit (Applied Biosystems). Probes for target genes were from TaqMan Assay-on-
Demand kits (Applied Biosystems). The only exceptions are natriuretic peptide
precursor type A (Nppa) and Nppb (Riehle et al., 2011) and mitochondrial- and
nuclear-encoded MRC subunits (Karamanlidis et al., 2013), where Brilliant III
Ultra-Fast SYBR Green QPCR Master Mix (Agilent Technologies) was used.
Samples were adjusted for total RNA content by TATA-binding protein. The rela-
tive expression of mRNAs was determined with a comparative method (2ddCT).
TheTaqManprobesusedand their accessionnumbers (GeneExpressionAssay,
Life Technologies) are MuRF1/Trim63 (Mm01185221_m1), Atrogin1/Fbxo32
(Mm00499523_m1), Myod1 (Mm00440387_m1), Myf5 (Mm00435125_
m1), Ddit3/CHOP (Mm00492097_m1), Fgf21 (Mm00840165_g1), Atf4
(Mm00515324_m1), Atf5 (Mm00459515_m1), Pdk4 (Mm00443325_m1), Cpt1b
(Mm00487200_m1), Ppar-a (Mm00440939_m1), Ppar-d (Mm01305434_m1),
Ppar-g (Mm00440945_m1), and Pgc-1a (Mm00447180_m1).
Blood Chemistry and Metabolite Analysis
Serum nonesterified fatty acid (NEFA) levels were determined with a colori-
metric kit (WAKO NEFA-C, Wako Life Sciences). NEFA standard solutions
were used for the linear regression plot, and absorbency was measured at468 Cell Metabolism 19, 458–469, March 4, 2014 ª2014 Elsevier Inc.550 nm in a Paradigm plate reader (Molecular Devices). Serum FGF21 concen-
trations were measured with a Mouse/Rat FGF-21 Quantikine ELISA Kit (R&D
Systems) according to the manufacturer’s instructions. Fed blood glucose
concentrations were measured after tail vein incision with glucose strips,
which were read for absorbance in a reflectance meter (ACCU-CHEK AVIVA).
Statistical Analysis
Student’s t tests were used to determine statistical significance. Error bars
represent SEM.
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